Is Private Equity Strengthening Health Care, or Eroding it from Within?

HealthSpark, Episode 16: Leemore Dafny, an applied microeconomist and former Deputy Director for Health Care and Antitrust at the Federal Trade Commission, examines how private equity-driven consolidation is reshaping health care spending and market stability, and whether these deals serve the public interest by protecting access, affordability, quality, and competition.

Leemore Dafny

Health Care Policy and Economics

How do investment strategies change patient care?

When private equity and other financial investors acquire health care organizations, they bring new incentives, time horizons, and performance targets. These could lead to expanded services and new capabilities with more efficient operations. But they can also push for higher margins and rapid growth in ways that could increase spending, put practices under financial strain, and destabilize organizational operations once the investors exit. The challenge is to structure these investments so that financial returns align with the long-term interests of patients and clinicians.

What happens when consolidation outpaces antitrust laws?

Many transactions that determine local or regional health care markets do not meet the federal threshold for merger review. A series of small practice acquisitions, for example, may steadily increase a firm's market share and bargaining power without a single, large reportable deal. This is a misalignment between how market power accumulates in practice and how competition is monitored in law. Those who depend on these markets must recognize how "stealth consolidation" can drive up spending, affect contract terms, and, ultimately, affect access to and quality of care.

Are states becoming watchdogs for health care deals?

As federal antitrust authorities are limited in addressing these smaller acquisitions, states are developing their own tools to oversee health care transactions. Some have adopted public-interest review statutes or approval processes that allow them to block, modify, or attach conditions to deals they deem likely to harm affordability, access, quality, or competition, even if they comply with federal antitrust standards. The result is a diverse set of state-level approaches that impact how organizations structure transactions, evaluate risk, and plan for long-term participation in certain markets. For health care organizations and financial investors operating globally and nationally, the ability to navigate and operate within this patchwork environment is becoming a necessary strategic capability.

Key question to take forward:

As you watch the video and consider your own setting, you might reflect on: 

How are shifts in who owns and controls health care organizations redefining whose interests are prioritized and what counts as value?

Sign Up to Receive HealthSpark Weekly

Related Program:

To learn more about how policy responds to consolidation in health care markets and how those choices impact access, competition, and equity, explore the Health Care Policy and Economics course in HealthXcelerate.

Health Care Policy and Economics

Examine how health policy is determined and implemented in the U.S. by understanding its effects at the national and state levels, and explore how governments carry out these policies, how stakeholders across the health care system engage with them, and how they influence cost-effectiveness, equity, and access.

  • HealthXcelerate
  • Online; Self-Paced
  • Group Enrollment Option
  • Start Today

Dates: Always Available

For: Health care professionals throughout the industry seeking better understanding of the health care system